MC> Vol.2 No.4, October 2013

Division of Hematology-Oncology, University of California, San Francisco, USA
Division of Hematology-Oncology, The University of Massachusetts Medical School, Worcester, USA
Department of Preventive Medicine, Northwestern University, Chicago, USA
Department of Preventive Medicine, Northwestern University, Chicago, USA
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA;
Division of Hematology-Oncology, Northwestern University, Chicago, USA;

 

Copyright © 2013 Neelima Vidula, Andrew M. Evens, Irene B. Helenowski, Borko Jovanovic, Jane N. Winter, Jayesh Mehta, Seema Singhal, Stephanie F. Williams, Olga Frankfurt, Jessica K. Altman, Joanne Monreal, Leo I. Gordon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Vidula, N. , Evens, A. , Helenowski, I. , Jovanovic, B. , Winter, J. , Mehta, J. , Singhal, S. , Williams, S. , Frankfurt, O. , Altman, J. , Monreal, J. and Gordon, L. (2013) Allogeneic and autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide conditioning therapy for relapsed/refractory non-Hodgkin lymphoma. Modern Chemotherapy, 2, 57-65. doi: 10.4236/mc.2013.24007.

 

Download citation as EndNote